Plus Therapeutics (PSTV) Long-Term Debt Repayments (2017 - 2025)
Plus Therapeutics has reported Long-Term Debt Repayments over the past 10 years, most recently at $3.7 million for Q1 2025.
- Quarterly Long-Term Debt Repayments rose 821.14% to $3.7 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $3.7 million through Dec 2025, down 7.33% year-over-year, with the annual reading at $3.7 million for FY2025, 7.33% down from the prior year.
- Long-Term Debt Repayments was $3.7 million for Q1 2025 at Plus Therapeutics, up from $3.6 million in the prior quarter.
- Over five years, Long-Term Debt Repayments peaked at $3.7 million in Q1 2025 and troughed at $402000.0 in Q1 2022.
- The 4-year median for Long-Term Debt Repayments is $402000.0 (2022), against an average of $992272.7.
- Year-over-year, Long-Term Debt Repayments changed 0.0% in 2023 and then skyrocketed 821.14% in 2025.
- A 4-year view of Long-Term Debt Repayments shows it stood at $402000.0 in 2022, then changed by 0.0% to $402000.0 in 2023, then soared by 794.03% to $3.6 million in 2024, then rose by 3.03% to $3.7 million in 2025.
- Per Business Quant, the three most recent readings for PSTV's Long-Term Debt Repayments are $3.7 million (Q1 2025), $3.6 million (Q2 2024), and $402000.0 (Q1 2024).